ArticleTargeted oncology2023
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Matteo Santoni et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it